Growth Hormone Therapy for a Child With Severe Cognitive Impairment.

Creator(s)

Vincent E. Horne
David E. Sandberg
Melissa Gardner
John Lantos, Children's Mercy HospitalFollow
David B. Allen

Document Type

Article

Publication Date

10-2018

Identifier

DOI: 10.1542/peds.2017-3938

Abstract

The expansion of growth hormone therapy over the last 3 decades has allowed for treatment of short stature for more children, resulting in increased height for many. However, treatment of idiopathic short stature remains controversial. Treatment decisions for disabled children with idiopathic short stature are even more complicated. We discuss a specific case of short stature in a disabled child and grapple with the ethical issues involved in the use of growth hormone.

Journal Title

Pediatrics

Volume

142

Issue

4

MeSH Keywords

Adolescent; Clinical Decision-Making; Cognitive Dysfunction; Human Growth Hormone; Humans; Male; Severity of Illness Index

Keywords

Adolescent; Clinical Decision-Making; Cognitive Dysfunction; Human Growth Hormone; Humans; Male; Severity of Illness Index

Recommended Citation

Horne VE, Sandberg DE, Gardner M, Lantos JD, Allen DB. Growth Hormone Therapy for a Child With Severe Cognitive Impairment. Pediatrics. 2018;142(4):e20173938. doi:10.1542/peds.2017-3938